Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imaging of Dissection of the Descending Aorta (DADI)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01648881
First received: July 20, 2012
Last updated: June 20, 2016
Last verified: June 2016
  Purpose
Patients with dissection of the descending aorta will be followed up according to a precise timeline.

Condition Intervention
Dissection of the Descending Aorta
Radiation: TEP-18FDG for every patient after aortic dissection

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Dissection of Aorta: Descending Part, Imaging

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Enrollment: 88
Study Start Date: May 2011
Estimated Study Completion Date: December 2018
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Intervention Details:
    Radiation: TEP-18FDG for every patient after aortic dissection

    Cover key details of the intervention. Must be sufficiently detailed to distinguish between arms of a study (e.g., comparison of different dosages of drug) and/or among similar interventions (e.g., comparison of multiple implantable cardiac defibrillators). For example, interventions involving drugs may include dosage form, dosage, frequency and duration.

    Example: 50 mg/m2, IV (in the vein) on day 5 of each 28 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.

    Other Name: TEP-18FDG
Detailed Description:
NMR baseline A PET Scanner will be performed minimum 3 months post dissection 6 months and every year during three years after PET scanner : CT scanner and blood sample
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with dissection of the descending aorta
Criteria

Inclusion Criteria:

  • 18 years
  • Seen for dissection of the descending aorta
  • Dissection of the descending aorta within the last three months
  • Affiliation to social security
  • Signed informed consent

Exclusion Criteria:

  • intervention programmed in relation with dissection of the descending aorta
  • Pregnant female
  • Adults without legal capacity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01648881

Locations
France
Pr Guillaume JONDEAU . Cardiologie. Hôpital Bichat
Paris, Ile de France, France, 75018
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France
Investigators
Principal Investigator: Guillaume JONDEAU Assistance Publique - Hôpitaux de Paris
  More Information

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT01648881     History of Changes
Other Study ID Numbers: P 100505  2011-A00238-33 
Study First Received: July 20, 2012
Last Updated: June 20, 2016
Health Authority: France: Ministry of Health
Individual Participant Data  
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Fluorodeoxyglucose F18
Radiopharmaceuticals
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on September 23, 2016